ArticleMolecular cancer therapeutics2014

Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.

Maoyong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.